Irene Conforti, Andrea Benzi, Irene Caffa, Santina Bruzzone, Alessio Nencioni, & Alberto Marra. (2023). Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents. MDPI AG.
Chicago Style (17th ed.) CitationIrene Conforti, Andrea Benzi, Irene Caffa, Santina Bruzzone, Alessio Nencioni, and Alberto Marra. Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents. MDPI AG, 2023.
MLA (9th ed.) CitationIrene Conforti, et al. Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.